Uniphar (UPR) Competitors GBX 228.75 -3.25 (-1.40%) As of 11:40 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesBuy This Stock UPR vs. UDG, HCM, GNS, CLIN, EMIS, INDV, VEC, ONT, CTH, and CRWShould you be buying Uniphar stock or one of its competitors? The main competitors of Uniphar include UDG Healthcare (UDG), HUTCHMED (HCM), Genus (GNS), Clinigen Group (CLIN), EMIS Group (EMIS), Indivior (INDV), Vectura Group (VEC), Oxford Nanopore Technologies (ONT), CareTech (CTH), and Craneware (CRW). These companies are all part of the "medical" sector. Uniphar vs. UDG Healthcare HUTCHMED Genus Clinigen Group EMIS Group Indivior Vectura Group Oxford Nanopore Technologies CareTech Craneware UDG Healthcare (LON:UDG) and Uniphar (LON:UPR) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, community ranking, dividends, analyst recommendations, institutional ownership, earnings and risk. Does the MarketBeat Community believe in UDG or UPR? UDG Healthcare received 511 more outperform votes than Uniphar when rated by MarketBeat users. However, 100.00% of users gave Uniphar an outperform vote while only 74.68% of users gave UDG Healthcare an outperform vote. CompanyUnderperformOutperformUDG HealthcareOutperform Votes51974.68% Underperform Votes17625.32% UnipharOutperform Votes8100.00% Underperform VotesNo Votes Do institutionals and insiders have more ownership in UDG or UPR? 45.3% of Uniphar shares are owned by institutional investors. 10.1% of Uniphar shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is UDG or UPR more profitable? Uniphar has a net margin of 1.68% compared to UDG Healthcare's net margin of 0.00%. Uniphar's return on equity of 13.18% beat UDG Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets UDG HealthcareN/A N/A N/A Uniphar 1.68%13.18%3.76% Do analysts prefer UDG or UPR? Uniphar has a consensus target price of GBX 310, suggesting a potential upside of 35.52%. Given Uniphar's stronger consensus rating and higher possible upside, analysts clearly believe Uniphar is more favorable than UDG Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UDG Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Uniphar 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is UDG or UPR a better dividend stock? UDG Healthcare pays an annual dividend of GBX 0.17 per share. Uniphar pays an annual dividend of GBX 2 per share and has a dividend yield of 0.9%. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Uniphar pays out 13.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Does the media favor UDG or UPR? In the previous week, UDG Healthcare's average media sentiment score of 0.00 equaled Uniphar'saverage media sentiment score. Company Overall Sentiment UDG Healthcare Neutral Uniphar Neutral Which has stronger earnings & valuation, UDG or UPR? Uniphar has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUDG Healthcare£1.25B0.00N/A£25.40N/AUniphar£3.03B0.23£51.04M£14.3815.91 SummaryUniphar beats UDG Healthcare on 11 of the 15 factors compared between the two stocks. Remove Ads Get Uniphar News Delivered to You Automatically Sign up to receive the latest news and ratings for UPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPR vs. The Competition Export to ExcelMetricUnipharMedical Distribution IndustryMedical SectorLON ExchangeMarket Cap£712.06M£365.69M£5.54B£2.52BDividend Yield0.77%1.33%5.35%4.90%P/E Ratio15.915.3823.25134.65Price / Sales0.2312.10361.26261,054.86Price / Cash9.979.9738.1627.90Price / Book1.791.796.494.45Net Income£51.04M£51.04M£3.21B£5.77B7 Day Performance-1.40%-3.06%-6.42%-1.85%1 Month Performance4.52%-2.72%-0.68%-2.65%1 Year Performance3.04%-10.26%6.05%103.94% Uniphar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPRUnipharN/AGBX 228.75-1.4%GBX 310+35.5%+2.7%£712.06M£3.03B15.913,000Gap DownHigh Trading VolumeUDGUDG HealthcareN/AN/AN/AN/A£2.72B£1.25B42.489,000HCMHUTCHMEDN/AGBX 226-3.0%N/A-7.1%£2.45B£771.01M-57.681,760Gap UpGNSGenus1.2806 of 5 starsGBX 1,952+0.4%GBX 2,150+10.1%+4.4%£1.28B£666.67M161.80480News CoverageHigh Trading VolumeCLINClinigen GroupN/AN/AN/AN/A£1.23B£565.60M64.691,000EMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560INDVIndivior2.3706 of 5 starsGBX 752-2.7%GBX 1,650+119.4%-56.6%£1.17B£1.40B-623.521,000High Trading VolumeVECVectura GroupN/AN/AN/AN/A£1.01B£190.60M8.209,200ONTOxford Nanopore Technologies2.4776 of 5 starsGBX 102.90-1.3%GBX 227.50+121.1%-11.5%£976.57M£184.78M-5.541,281High Trading VolumeCTHCareTechN/AN/AN/AN/A£850.02M£495.40M10,714.2911,000CRWCraneware1.8703 of 5 starsGBX 1,847.50-0.7%GBX 2,800+51.6%-20.5%£793.81M£230.77M68.26734News CoverageNegative News Remove Ads Related Companies and Tools Related Companies UDG Alternatives HCM Alternatives GNS Alternatives CLIN Alternatives EMIS Alternatives INDV Alternatives VEC Alternatives ONT Alternatives CTH Alternatives CRW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:UPR) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uniphar plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Uniphar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.